25-1287
Authorize the Chief Executive Officer to execute documents necessary to participate in the National Opioids Settlements with multiple opioid manufacturer defendants, including: (1) Sandoz, Inc.; (2) Purdue Pharma L.P. & Sackler Family; and (3) Other several small generic pharmaceutical opioid manufacturers collectively. (Fiscal Impact: Increased Revenue; General Fund; Not Budgeted; Discretionary)
- Committee
- Board of Supervisors
- Requested by
- County Counsel
- Introduced
- July 7, 2025
- On agenda
- September 9, 2025
- Passed
- December 31, 2025